The Quay, 100 Queens Quay East, 3rd Floor
In Person
Canada’s life sciences sector is gaining ground, ranking 1st globally among G7 countries in the number of clinical trials per population, and home to over 3,500 life sciences companies in Ontario alone. But despite this success, we are missing one key ingredient - the capital to scale these firms at home. Despite more than $3 trillion in Canadian pension assets, fewer than 40% of startups receive funding from domestic sources What will it take to fuel the growth we need to anchor this critical sector and compete on a global scale?
If you’re building, funding, or shaping innovation, this conversation is for you.
Join investors, founders, and policymakers for a high-impact breakfast focused on one of the sector’s most pressing barriers: access to domestic growth capital. Walk away with the insights and connections needed to move from potential to scale.
With U.S. protectionism on the rise and global alliances shifting, it’s more important than ever for the Toronto region to build a stronger domestic investment environment.
We have the talent, research strength, and global demand but without a stronger homegrown capital base, we risk losing innovation, IP, and opportunity to foreign markets.
Don’t miss this critical discussion on how to align Canada’s capital with its innovation ecosystem to unlock growth: scaling companies, creating jobs, and strengthening economic resilience.
You’ll hear:
- What Canadian investors are looking for in the life sciences space
- Policy changes that could unlock new growth
- How to connect early-stage science with the funding needed to scale
It’s Worth Your Morning
This high-impact session brings the right people into the room to spark the next phase of growth for Canada’s life sciences economy.
- Investors & VCs: Hear what’s needed to unlock returns and connect with founders ready to scale.
- Corporate Venture Arms: Discover promising innovations and explore new partnership pathways.
- Founders & Scale-Ups: Learn how to access domestic capital and scale on home soil.
- Policymakers & Ecosystem Leaders: Understand what’s holding capital back and how smart policy can change that.
- Business Leaders Across Sectors: Get insight into capital trends and investment strategies that shape Canada’s broader innovation economy.
Canada has the capital now we need the will. If we want to lead in life sciences, we need to invest like it. Join us to help shape the strategies that will unlock Canada’s innovation economy and fuel the sector’s next era of growth.
- Venture capital firms and institutional investors
- Corporate venture arms of global companies
- Life sciences founders and scale-ups
- Policymakers, accelerators, and industry leaders
Agenda
8:00 – 8:30 am: Arrival, Registration, and Networking Breakfast
8:30 – 8:35 am: Welcome and Introductory Remarks
- Giles Gherson, President & CEO, Toronto Region Board of Trade
8:35 – 8:45 am: Keynote Address: Building a Life Sciences Company in Toronto: A Business Leader’s Perspective
Hear directly from a leading entrepreneur about what it takes to build and scale a life sciences company in the Toronto region. This keynote will explore the real-world challenges and opportunities in funding, talent, and commercialization — and what’s needed to better support business growth in Canada’s life sciences ecosystem.
Speaker:
- Sydney Robinson, CEO and Co-founder, Vessl Prosthetics Inc.
8:45 – 9:25 am: Panel Discussion: Investing in Innovation: Building a Competitive Life Sciences Capital Ecosystem
Canada’s life sciences sector is rich in talent and discovery, but access to capital remains a key barrier to growth. This panel brings together leading capital providers to explore what’s holding back investment in domestic innovation — and what needs to change. Panelists will discuss the policies, incentives, and ecosystem supports needed to unlock capital at scale, and share what investors are looking for when backing Canadian life sciences ventures.
Speakers:
- Scott McAuley, Head of Research Equity Research Analyst, Paradigm Capital
- Gordon C. McCauley, President & CEO, AdMare BioInnovations
9:25 – 9:30 am: Closing Remarks
- Giles Gherson
9:30 – 10:00 am: Networking
Speakers
-
Scott McAuley
Head of Research, Paradigm Capital
-
Gordon C. McCauley
President and CEO, adMare BioInnovations
-
Sydney Robinson
CEO and Co-Founder CEO, Vessl Prosthetics
Tickets & Registration
Members
- Single Ticket: $149
- Table of 10: $1,341
Non-Members
- Single Ticket: $199
- Table of 10: $1,990